Hepatocellular Carcinoma Clinical Trials in Würzburg
4 recruitingWürzburg, Germany
Showing 1–4 of 4 trials
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994
Recruiting
Phase 2
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients
Hepatocellular Carcinoma
Enrico De Toni83 enrolled3 locationsNCT05844046
Recruiting
Phase 2
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich106 enrolled7 locationsNCT04224636
Recruiting
The European NAFLD Registry
Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334